Synthetic biology yields new approach to gene therapy

Bioengineers at The University of Texas at Dallas have created a novel gene-delivery system that shuttles a gene into a cell, but only for a temporary stay, providing a potential new gene-therapy strategy for treating disease.

CEO compensation study examines factors in excess returns

Of many issues associated with CEO compensation, excess returns are likely among the most controversial. UT Dallas researchers examined how boards face pressures when trying to control this problem.

'Patent trolls' jeopardize innovation, study finds

(Phys.org) —New research co-authored by a Naveen Jindal School of Management accounting professor suggests that companies that don't manufacture goods or products but sue companies that do threaten innovation and economic ...

page 8 from 25